Biochemical and clinical markers form the backbone of risk assessment and therapeutic decision-making across cardio–reno–metabolic disorders. Among these, parameters like albumin, calcium, NT-proBNP, and glycemic indices play a pivotal role in predicting disease progression, guiding therapy, and improving outcomes.
Moderated by Dr. Sourabh Sharma, this episode convenes Dr. Pushpraj Patel (Cardiology), Dr. Neeraj Jain (Nephrology), and Dr. Vikram Singh Chouhan (Endocrinology) to decode the clinical significance and interconnections of these essential biomarkers.
Join this knowledge-rich discussion to gain deeper insights into the “markers that matter” and how they can help clinicians move from reactive to predictive management.